Revive Therapeutics (FRA:31R) Accounts Payable & Accrued Expense : €2.17 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Revive Therapeutics Accounts Payable & Accrued Expense?

Revive Therapeutics's quarterly accounts payable & accrued expense declined from Jun. 2024 (€2.24 Mil) to Sep. 2024 (€2.14 Mil) but then increased from Sep. 2024 (€2.14 Mil) to Dec. 2024 (€2.17 Mil).

Revive Therapeutics's annual accounts payable & accrued expense declined from Jun. 2022 (€3.00 Mil) to Jun. 2023 (€2.29 Mil) and declined from Jun. 2023 (€2.29 Mil) to Jun. 2024 (€2.24 Mil).

Revive Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Revive Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Accounts Payable & Accrued Expense Chart

Revive Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.20

0.35

3.00

2.29

2.24

Revive Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2.13	2.16	2.24	2.14	2.17

Revive Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Revive Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (FRA:31R) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

RVVTF:USA RVV:Canada

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.

Revive Therapeutics Headlines

No Headlines